Introducing Empower T2i
Empower T2i is free structured education program for people living with type 2 diabetes using insulin, which is facilitated by Credentialled Diabetes...
Read More
Escalation of diabetes therapeutic technology to improve glycaemia and quality of life: A case from the ORACL trial
Older adults with long-duration type 1 diabetes (T1D) can have additional health challenges to those experienced by...
Case study: Treatment Induced Neuropathy of Diabetes after rapid improvement in glycaemia following new diagnosis of autoimmune diabetes
Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...
Steroid-Induced Hyperglycaemia
Glucocorticoids are an effective anti-inflammatory and immunosuppressant used in the treatment of many medical conditions, including COVID-19. The use...
Bone health in type 1 diabetes: mechanisms and assessment
Osteoporosis is a systemic condition in which low bone mass and impairments in bone microstructure leads to increased skeletal fragility and a...
Telehealth Beyond the Pandemic
“There is a very important role for face-to-face [care], but equally that supplementary role for telehealth can give people access when they need...
Member Profile – Meet Shannon Lin
Shanshan (Shannon) Lin is a member of the ADE Editorial Advisory Group, the Course Coordinator of the ADEA accredited Diabetes Education and Management...
Editors Column
In our first edition of the ADE for 2022 we have articles covering a wide variety of topics relevant to our work as diabetes educators.
...Type 2 Diabetes Remission Position Statement
A joint position statement has been published from a collaboration of ADEA, ADS and Diabetes Australia.
...Can low carb help those living with type 2 diabetes into remission?
In Australia, 1.3 million people are living with diabetes and 100,000 people are being diagnosed each year. In addition, two million are living with...